3 wunderkinds took the stage at #STATSummit to talk about their research
all doing potentially transformational research, they expressed concerned abt access to the fruits of their work — @SciFleur interviewed @jmartinrufino@_dianes_ & Ramisa Fariha
https://t.co/s4x8hwIU8G
I’m honored to be one of this year’s #STATWunderkind cohort! So appreciative of all the opportunities and mentors I’ve had along the way @ChrisAWalsh1@BCH_PoduriLab@BCHNeuroRes.
Check out the other award winners at the link below!
With the first tweet of 2024, I am happy to announce that I am officially starting my lab @BWHNeurology next month: https://t.co/8d7ZLi185A. We are recruiting at every level, but particularly looking for talented postdocs and a lab manager, please RT and spread the word.
Excited to share our preprint on brain mosaicism in sporadic amyotrophic lateral sclerosis (sALS) and frontotemporal dementia (sFTD) that implicates surprising mechanisms. https://t.co/Wigx9dHVyO. 1/10
A truly historic moment, first CRISPR therapy approved!
Key ingredients: astute clinical observation on HbF and SS (Janet Watson ca 1948), basic developmental biology, human genetics including GWAS for target ID, and of course CRISPR
https://t.co/cLIY2eahDr
Genotype before phenotype will become the norm.
Genomic testing is poised to have a role similar to EEG, MRI, and LP in the arsenal of a #ChildNeurologist.
A National Neurogenetics Curriculum is needed to prepare residents. #MedSocial30#PECN#CNS@kuntal_sen_
(1/5) A new study from @BCH_PoduriLab focused on the diagnostic yield and clinical utility of genetic sequencing for patients with unexplained pediatric epilepsy. The study leveraged a prospectively ascertained, single-institution cohort of 522 (more now) children.
Shyam Akula in @ChrisAWalsh1 lab spearheaded this great work on novel genes implicated in polymicrogyria. It was such a pleasure working with the talented trainees and clinicians on this project! https://t.co/FnkxlJOp7N
Our own Lacey Smith and colleagues have published the first practice guideline for genetic testing in the epilepsies. There are now formal recommendations that include broad-based testing for all individuals with unexplained epilepsy! Check it out here: https://t.co/JlC8qc5t6n
Today, we’re introducing a new model that eliminates accept/reject decisions.
By publishing every paper with eLife reviews as a Reviewed Preprint, we plan to restore autonomy to authors, ensuring that they will be judged by what, not where, they publish. https://t.co/OAsiOVFStI
Congratulations Richard O. Hynes, Erkki Ruoslahti, and Timothy A. Springer, 2022 #LaskerAward winners! — “for discoveries concerning the #integrins—key mediators of cell-matrix and cell-cell adhesion in physiology and disease”.
@MIT@sbpdiscovery@harvardmed#Lasker2022